Anna Kukharenok advises public and private companies on corporate law matters. She has represented clients in domestic and cross-border mergers, acquisitions, financings, corporate restructurings, and other strategic transactions. In addition, she has experience advising companies on corporate governance matters.
Anna has represented clients in a range of industries, including cosmetics, real estate, technology, life sciences, and health care. Her recent representations include Astellas Pharma in its $5.9 billion acquisition of Iveric Bio, Shiseido in its $450 million acquisition of Dr. Dennis Gross Skincare, and Reneo Pharmaceuticals in its pending reverse merger with OnKure. Other representative matters include transactions involving Five9, Intel, Organon, and Sumitomo Pharma.
Anna also maintains an active pro bono practice, assisting nonprofits in their corporate governance matters, representing individuals seeking asylum in the United States, and representing survivors of human trafficking in acquiring various forms of relief.
Anna is author of "From Bus Bans on Religious Advertisements to Beyond: Why Religion Is More Appropriately Classified as a Viewpoint Rather Than a Subject Matter," 59 San Diego L. Rev. 531 (2022).
- University of San Diego (J.D. summa cum laude 2022; Order of the Coif); University of California, Los Angeles (B.A. in Psychology cum laude 2018)
- California
- Extern to Judge Thomas J. Whelan (Fall 2020) and Magistrate Judge William V. Gallo (Summer 2020), U.S. District Court, Southern District of California
- Russian